Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-Remitting Multiple Sclerosis”

Showing 20 of 0 results

Not applicableEnded earlyNCT01905527
What this trial is testing

Adherence Trial With MS LifeLines ® Services

Who this might be right for
Multiple SclerosisRelapsing-Remitting
EMD Serono 306
Post-approval studies (Phase 4)Study completedNCT02587065
What this trial is testing

Plegridy Satisfaction Study in Participants

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Biogen 193
Not applicableStudy completedNCT00203086
What this trial is testing

Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 30
Post-approval studies (Phase 4)Study completedNCT02471560
What this trial is testing

Tecfidera and the Gut Microbiota

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 36
Not applicableStudy completedNCT02247310
What this trial is testing

BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With Betaferon

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Bayer 498
Not applicableStudy completedNCT01158183
What this trial is testing

Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer 226
Testing effectiveness (Phase 2)Study completedNCT02495766
What this trial is testing

Autologous Mesenchymal Stromal Cells for Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
Banc de Sang i Teixits 8
Not applicableStudy completedNCT03500328
What this trial is testing

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Johns Hopkins University 900
Not applicableStudy completedNCT01491100
What this trial is testing

Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Bayer 1,085
Early research (Phase 1)Study completedNCT00242177
What this trial is testing

Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University of Illinois at Chicago 30
Not applicableStudy completedNCT07789171
What this trial is testing

Synbiotic Supplementation as a Part of Dietary Modification in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
Hacettepe University 38
Not applicableWithdrawnNCT04925778
What this trial is testing

Observational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl Fumarate

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Banner Life Sciences LLC
Large-scale testing (Phase 3)Study completedNCT01167426
What this trial is testing

Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 148
Not applicableStudy completedNCT01125475
What this trial is testing

A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Merck KGaA, Darmstadt, Germany 61
Early research (Phase 1)Ended earlyNCT02326935
What this trial is testing

Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
American CryoStem Corporation 2
Testing effectiveness (Phase 2)WithdrawnNCT01714089
What this trial is testing

Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Revalesio Corporation
Early research (Phase 1)Ended earlyNCT02423083
What this trial is testing

Oral Guanabenz for Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 2
Not applicableWithdrawnNCT05482542
What this trial is testing

Optimal Conditioning Regimen for Autologous Transplantation of Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Scripps Health
Not applicableStudy completedNCT03872583
What this trial is testing

Understanding Magnetic Resonance Imaging in Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingClinically Isolated Syndrome
Universitätsklinikum Hamburg-Eppendorf 120
Post-approval studies (Phase 4)Looking for participantsNCT06733922
What this trial is testing

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)
Novartis Pharmaceuticals 224
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation